113 related articles for article (PubMed ID: 12498174)
1. Outpatient pelvic inflammatory disease treatment as effective as inpatient care, study finds.
Levenson D
Rep Med Guidel Outcomes Res; 2002 Jun; 13(11):9-10, 12. PubMed ID: 12498174
[No Abstract] [Full Text] [Related]
2. Outpatient treatment of pelvic inflammatory disease with cefoxitin and doxycycline.
Wølner-Hanssen P; Paavonen J; Kiviat N; Young M; Eschenbach DA; Holmes KK
Obstet Gynecol; 1988 Apr; 71(4):595-600. PubMed ID: 3353051
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial.
Ness RB; Trautmann G; Richter HE; Randall H; Peipert JF; Nelson DB; Schubeck D; McNeeley SG; Trout W; Bass DC; Soper DE
Obstet Gynecol; 2005 Sep; 106(3):573-80. PubMed ID: 16135590
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial.
Ness RB; Soper DE; Holley RL; Peipert J; Randall H; Sweet RL; Sondheimer SJ; Hendrix SL; Amortegui A; Trucco G; Songer T; Lave JR; Hillier SL; Bass DC; Kelsey SF
Am J Obstet Gynecol; 2002 May; 186(5):929-37. PubMed ID: 12015517
[TBL] [Abstract][Full Text] [Related]
5. Multicenter randomized trial of ofloxacin versus cefoxitin and doxycycline in outpatient treatment of pelvic inflammatory disease. Ambulatory PID Research Group.
Martens MG; Gordon S; Yarborough DR; Faro S; Binder D; Berkeley A
South Med J; 1993 Jun; 86(6):604-10. PubMed ID: 8506477
[TBL] [Abstract][Full Text] [Related]
6. Use of an institutional intervention to improve quality of care for adolescents treated in pediatric ambulatory settings for pelvic inflammatory disease.
Trent M; Judy SL; Ellen JM; Walker A
J Adolesc Health; 2006 Jul; 39(1):50-6. PubMed ID: 16781961
[TBL] [Abstract][Full Text] [Related]
7. Adherence to oral therapies in pelvic inflammatory disease.
Dunbar-Jacob J; Sereika SM; Foley SM; Bass DC; Ness RB
J Womens Health (Larchmt); 2004 Apr; 13(3):285-91. PubMed ID: 15130257
[TBL] [Abstract][Full Text] [Related]
8. Treatment of acute pelvic inflammatory disease in the ambulatory setting: trial of cefoxitin and doxycycline versus ampicillin-sulbactam.
Kosseim M; Ronald A; Plummer FA; D'Costa L; Brunham RC
Antimicrob Agents Chemother; 1991 Aug; 35(8):1651-6. PubMed ID: 1929337
[TBL] [Abstract][Full Text] [Related]
9. Improvement in the clinical cure rate of outpatient management of pelvic inflammatory disease following a change in therapy.
Piyadigamage A; Wilson J
Sex Transm Infect; 2005 Jun; 81(3):233-5. PubMed ID: 15923292
[TBL] [Abstract][Full Text] [Related]
10. [Effects of a programme for structured outpatient follow-up care after inpatient rehabilitation of obese children and adolescents--a multicentre, randomized study].
van Egmond-Fröhlich A; Bräuer W; Goldschmidt H; Hoff-Emden H; Oepen J; Zimmermann E
Rehabilitation (Stuttg); 2006 Feb; 45(1):40-51. PubMed ID: 16468112
[TBL] [Abstract][Full Text] [Related]
11. Trends in illness severity and length of stay in inner-city adolescents hospitalized for pelvic inflammatory disease.
Kaul P; Stevens-Simon C; Saproo A; Coupey SM
J Pediatr Adolesc Gynecol; 2008 Oct; 21(5):289-93. PubMed ID: 18794025
[TBL] [Abstract][Full Text] [Related]
12. Comparison of three regimens recommended by the Centers for Disease Control and Prevention for the treatment of women hospitalized with acute pelvic inflammatory disease.
Hemsell DL; Little BB; Faro S; Sweet RL; Ledger WJ; Berkeley AS; Eschenbach DA; Wölner-Hanssen P; Pastorek JG
Clin Infect Dis; 1994 Oct; 19(4):720-7. PubMed ID: 7803638
[TBL] [Abstract][Full Text] [Related]
13. Pelvic inflammatory disease.
Brunham RC; Gottlieb SL; Paavonen J
N Engl J Med; 2015 May; 372(21):2039-48. PubMed ID: 25992748
[No Abstract] [Full Text] [Related]
14. When to treat adolescents with pelvic inflammatory disease as outpatients.
Shrier LA
J Pediatr Adolesc Gynecol; 1998 Nov; 11(4):191-2. PubMed ID: 9806131
[No Abstract] [Full Text] [Related]
15. A cost-effective approach to managing infectious disease.
Wright RA
Consultant; 1989 May; 29(5):143-6, 150, 155. PubMed ID: 10292917
[TBL] [Abstract][Full Text] [Related]
16. An audit of outpatient management of pelvic inflammatory disease.
Piyadigamage A; Wilson JD
Int J STD AIDS; 2002 Aug; 13(8):577-9. PubMed ID: 12194744
[TBL] [Abstract][Full Text] [Related]
17. The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy.
Rodger MA; Gagné-Rodger C; Howley HE; Carrier M; Coyle D; Wells PS
Thromb Res; 2003; 112(1-2):13-8. PubMed ID: 15013267
[TBL] [Abstract][Full Text] [Related]
18. [Rehabilitation after ST-elevation myocardial infarction: inpatient, outpatient or none?].
Hoberg E
Dtsch Med Wochenschr; 2004 Feb; 129(7):317-20. PubMed ID: 14765331
[No Abstract] [Full Text] [Related]
19. Comparison of ceftizoxime versus combination therapy in the treatment of pelvic inflammatory disease (PID).
Wikler MA; Moonsammy GI; Hemsell DL
J Chemother; 1989 Jul; 1(4 Suppl):882-3. PubMed ID: 16312685
[No Abstract] [Full Text] [Related]
20. Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry.
Fonarow GC; Yancy CW; Albert NM; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; Mehra M; O'Connor CM; Reynolds D; Walsh MN
Am Heart J; 2007 Jul; 154(1):12-38. PubMed ID: 17584548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
